Svensk Kirurgi 5-16

255 SVENSK KIRURGI • VOLYM 74 • NR 5 • 2016 Avhandlingsreferat Svensk Förening för Kärlkirurgi delar årligen ut Stora Kärlex-priset till medlem som under året disputerat med kärlkirurgisk avhand- ling. I år gick priset till Moncef Zarrouk. Att identifiera orsaken till att indivi- der ej hörsammar kallelsen är mycket viktigt då detta påverkar kostnadsef- fektiviteten av all typ av screening. Med hjälp av externa professionella reklambyråer kan man öka hörsam- heten till medicinska ändamål som till exempel AAA screening. Slutligen så är det fortfarande kostnadseffek- tivt att screena för AAA när preva- lensen av sjukdomen minskat. Allt fler opereras endovaskulärt och alla erbjuds sekundärpreventiv medicinsk behandling.  Referenser 1. Moll FL, Powell JT, Fraedrich G, Verzini F, Haulon S, Waltham M, et al. Manage- ment of Abdominal Aortic Aneurysms. Clinical Practice Guidelines of the Euro- pean Society for Vascular Surgery. Eur J Vasc Endovasc Surg 2011; 41:S1eS58. 2. Heather BP, Poskitt KR, Earnshaw JJ, Whyman M, Shaw E. Population screening reduces mortality rate from aortic aneurysm in men. Br J Surg. 2000;87:750-753. 3. Socialstyrelsen. Dödsorsaker 2013 – Causes of Death 2013 Stockholm: Social- styrelsen; 2013.Artikelnummer: 2014-8-5. ISBN 978-91-7555-202-6. 4. Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA, et al. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002;360:1531-9. 5. Scott RA, Wilson NM, Ashton HA, Kay DN. Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study. Br J Surg 1995;82:1066- 70. 6. Norman PE, Jamrozik K, Lawrence- Brown MM, Le MT, Spencer CA, Tuohy RJ, et al. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneu- rysm. BMJ 2004;329:1259. 7. Lindholt JS, Juul S, Fasting H, Henne- berg EW. Hospital costs and benefits of screening forabdominal aortic aneurysms. Results from a randomised population screening trial. Eur JVasc Endovasc Surg 2002;23:55-60. 8. Svensjo S, Bjorck M, Wanhainen A. Current prevalence of abdominal aortic aneurysm in 70- year-old women. British journal of surgery 2012;100(3):367-372. 9. Zarrouk, M. Holst, J, Malina, M, Lind- blad, B, Wann-Hansson, C.,Rosvall, M., et al. A. The importance of socioeconomic factors for compliance and outcome at screening for abdominal aortic aneu- rysm in 65-year-old men. J Vasc Surg 2013;58(1):50-55. 10. Wanhainen A, Bjorck M. The Swedish experience of screening for abdo- minal aortic aneurysm. J Vasc Surg 2011;53(4):1164-1165. 11. Linne A, Leander K, Lindstrom D, Tornberg S, Hultgren R. Reasons for non-participation in population-based abdominal aortic aneurysm screening. Br J Surg 2014;101(5):481-487. 12. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: WHO;1968. Available from: http:// www.who.int/bulletin/volumes/86/4/07- 050112BP.pdf 13. Zarrouk M, Keshavarz K, Lindblad B, Gottsäter A. APC-PCI complex levels for screening of AAA in patients with peripheral atherosclerosis. Thrombolysis 2013;36:495-500. 14. Zarrouk M, Gottsäter A, Malina M, Holst J. A Academic vascular unit collaboration with advertising agency yield highercom- pliance in screening for abdominal aortic aneurysm. J Med Screen 2014;21:216- 218. 15. Zarrouk M, Lundqvist A, Holst J, Troëng T, Gottsäter A. Cost-effectiveness of screening for abdominal aortic aneurysm incombination with medical intervention in patients with small aneurysms. (Revised).